Scinovex
articleTop 10% cited

Liposomes for the sustained drug release in vivo

Biochimica et Biophysica Acta (BBA) - Biomembranes · 1990 · Vol. 1029(1) · pp. 91–97
Gabriele BlumeGregor Cevc
Lipid Membrane Structure and BehaviorRNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryLiposomeVesiclePhosphatidylcholineChemistryPhosphatidylethanolamineIn vivoPhospholipidPEG ratioDrug carrierBiophysics

MeSH terms

Drug CarriersDrug CompoundingHumansKineticsLipid BilayersLiposomesMetabolic Clearance RatePhagocytesPhagocytosisPhosphatidylcholinesPhosphatidylethanolaminesSurface Properties

Funding

  • Deutsche Forschungsgemeinschaft
Citations
698
FWCI
10.17
field-weighted impact
References
19
Percentile
99%
vs. same field & year
Citations per year
Cited by
Non-ionic surfactant based vesicles (niosomes) in drug delivery
International Journal of Pharmaceutics · 1998 · 988 citations
Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times
Biochimica et Biophysica Acta (BBA) - Biomembranes · 1991 · 542 citations
Doxil® — The first FDA-approved nano-drug: Lessons learned
Journal of Controlled Release · 2012 · 4,472 citations
Liposomal drug delivery systems: From concept to clinical applications
Advanced Drug Delivery Reviews · 2012 · 4,571 citations
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Angewandte Chemie International Edition · 2010 · 3,412 citations
Nano-oncology: drug delivery, imaging, and sensing
Analytical and Bioanalytical Chemistry · 2006 · 455 citations
Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System
Journal of Pharmaceutical Sciences · 1995 · 630 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.